Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Cytotherapy|July 29, 2014
Reference materials for cellular therapeuticsChristopher A Bravery, Anna FrenchStem Cells and Development|September 23, 2014
Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense?Christopher A BraveryJournal of the Royal Society, Interface|September 24, 2010
Regulating interface science healthcare products: myths and uncertaintiesChristopher A BraveryMolecular Therapy. Methods & Clinical Development|July 9, 2020
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other BiologicalsMagdi Elsallab, Christopher A Bravery, Andreas Kurtz, et al.Experimental Physiology|November 7, 2006
Increasing renal mass improves survival in anephric rats following metanephros transplantationDamian Marshall, Mark R Dilworth, Marc Clancy, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2007
Development and functional capacity of transplanted rat metanephroiMark Robert Dilworth, Marc James Clancy, Damian Marshall, et al.Cell Stem Cell|October 5, 2010
Mesenchymal stromal cells: facilitators of successful transplantation?Karen English, Anna French, Kathryn J WoodRejuvenation Research|January 8, 2014
CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapiesAnna French, Kim Bure, David A BrindleyRejuvenation Research|March 9, 2013
Commercialization of regenerative medicine: learning from spin-outsAnna French, R Lee Buckler, David A BrindleyBrain Injury|April 1, 2016
Participation in communication activities following traumatic brain injury: A time use diary studyEmma Finch, Anna French, Rachel J Ou, et al.Pageof 3